Immunotherapy Before Surgery Keeps Bowel Cancer Away in All 32 Trial Patients
Nearly three years on, none of the 32 NEOPRISM-CRC patients have relapsed — a striking result that still needs confirmation in larger, randomized trials.
Oct 14, 20263 views
